Download PDF

1. Company Snapshot

1.a. Company Description

CompuGroup Medical SE & Co. KGaA develops and sells software and information technology solutions for the healthcare sector worldwide.It operates in four segments: Ambulatory Information Systems (AIS), Pharmacy Information Systems (PCS), Hospital Information Systems (HIS), and Consumer & Health Management Information Systems (CHS).The AIS segment provides practice management software and electronic medical records for registered physicians, medical care centers, and physicians networks, as well as offers supplementary Internet and intranet solutions.


The PCS segment provides administrative and billing-related software applications for pharmacies.Its software solution provides information and decision support to manage various aspects of supply chain for medication.The HIS segment provides clinical and administrative solutions for the inpatient sector.


This segment serves acute care hospitals, rehabilitation centers, social services, multi-location hospital networks and regional care organizations, and medical laboratories.The CHS segment provides IT security services, data-based product offers, software interface for sharing of information, clinical decision-making support, and medication and treatment databases for healthcare service providers, as well as digital healthcare stock, consumer portals, and mobile apps.This segment also offers security solutions for healthcare providers.


It serves pharmaceutical companies, health insurance companies, and other healthcare IT companies and consumers.The company was formerly known as CompuGroup Medical SE and changed its name to CompuGroup Medical SE & Co. KGaA in June 2020.CompuGroup Medical SE & Co. KGaA was founded in 1987 and is headquartered in Koblenz, Germany.

Show Full description

1.b. Last Insights on COP

CompuGroup Medical SE & Co. KGaA's recent performance was driven by strategic acquisitions and a focus on recurring revenues. Despite a dip in organic revenue, the company showcased resilience through targeted investments. The Q4 2024 earnings call highlighted the company's efforts to navigate industry challenges, with a focus on expanding its presence through strategic acquisitions. Additionally, CompuGroup Medical has been actively managing its capital structure, with a recent share buyback announcement, which is expected to boost shareholder value by reducing the number of outstanding shares.

1.c. Company Highlights

2. Transcript Summary

Unfortunately this company is not part of our coverage yet. But as part of your subscription plan you can request it by clicking just below and we'll process.

Request Coverage

3. NewsRoom

Card image cap

Is There Now An Opportunity In CompuGroup Medical SE & Co. KGaA (HMSE:COP)?

Nov -09

Source:

Card image cap

Is CompuGroup Medical (XTRA:COP) Undervalued? A Closer Look at the Recent Share Price Momentum and Valuation

Sep -29

Source:

Card image cap

CompuGroup Medical SE & Co KgaA (WBO:COP) Q1 2025 Earnings Call Highlights: Navigating ...

May -01

Source:

Card image cap

CompuGroup Medical SE & Co KgaA (CMPUY) Q4 2024 Earnings Call Highlights: Navigating ...

Mar -07

Source:

Card image cap

CVC Offers to Take CompuGroup Private in $1.2 Billion Deal

Dec -09

Source:

Card image cap

Germany's CompuGroup in talks about potential offer by CVC

Dec -09

Source:

Card image cap

CVC bids for Germany's CompuGroup Medical at 51% premium

Dec -09

Source:

Card image cap

CVC In Talks to Take German Software Firm CompuGroup Private

Dec -08

Source:

4. Business Breakdown

4.a. Revenues by Country

4.b. Revenues by Segment

5. Expected revenues mid-term growth (3.68%)

6. Segments

Ambulatory Information Systems

Expected Growth: 3.5%

CompuGroup Medical SE & Co. KGaA's Ambulatory Information Systems segment growth of 3.5% is driven by increasing adoption of digital healthcare solutions, rising demand for efficient clinical workflows, and growing need for data-driven decision making. Additionally, the shift towards value-based care and expanding healthcare infrastructure in emerging markets also contribute to the segment's growth.

Hospital Information Systems

Expected Growth: 3.8%

CompuGroup Medical SE & Co. KGaA's Hospital Information Systems segment growth of 3.8% is driven by increasing demand for digital healthcare solutions, government initiatives promoting healthcare IT adoption, and the company's strategic expansion into emerging markets. Additionally, the segment benefits from the growing need for efficient clinical workflows, patient data management, and interoperability, further fueling growth.

Consumer and Health Management Information Systems

Expected Growth: 4.2%

CompuGroup Medical SE & Co. KGaA's 4.2% growth in Consumer and Health Management Information Systems is driven by increasing demand for digital healthcare solutions, government initiatives promoting healthcare IT adoption, and strategic acquisitions expanding the company's product portfolio and geographic reach.

Pharmacy Information Systems

Expected Growth: 3.2%

CompuGroup Medical SE & Co. KGaA's Pharmacy Information Systems segment growth of 3.2% is driven by increasing adoption of digital healthcare solutions, rising demand for efficient pharmacy management, and government initiatives promoting healthcare IT infrastructure development.

Other

Expected Growth: 3.9%

CompuGroup Medical SE & Co. KGaA's 3.9% growth in 'Other' segment is driven by increasing demand for digital healthcare services, expansion into new markets, and strategic partnerships. Additionally, the company's focus on innovation, cost savings initiatives, and effective capital allocation also contribute to this growth.

7. Detailed Products

Ambulatory Information Systems (AIS)

CompuGroup Medical's Ambulatory Information Systems (AIS) provide comprehensive clinical and administrative solutions for ambulatory care providers, including electronic health records, practice management, and revenue cycle management.

Pharmacy Information Systems (PIS)

CompuGroup Medical's Pharmacy Information Systems (PIS) offer integrated solutions for pharmacy management, including prescription management, inventory management, and billing and reimbursement.

Hospital Information Systems (HIS)

CompuGroup Medical's Hospital Information Systems (HIS) provide comprehensive clinical and administrative solutions for hospitals, including electronic health records, departmental systems, and hospital information systems.

Laboratory Information Systems (LIS)

CompuGroup Medical's Laboratory Information Systems (LIS) offer integrated solutions for laboratory management, including specimen tracking, result reporting, and quality control.

Radiology Information Systems (RIS)

CompuGroup Medical's Radiology Information Systems (RIS) provide comprehensive solutions for radiology departments, including patient scheduling, image management, and reporting.

Telemedicine Solutions

CompuGroup Medical's Telemedicine Solutions enable remote consultations, virtual care, and patient engagement, improving access to healthcare services.

Data Analytics and Business Intelligence

CompuGroup Medical's Data Analytics and Business Intelligence solutions provide insights and analytics to improve healthcare operations, patient care, and business performance.

8. CompuGroup Medical SE & Co. KGaA's Porter Forces

Forces Ranking

Threat Of Substitutes

The threat of substitutes for CompuGroup Medical SE & Co. KGaA is medium due to the presence of alternative healthcare IT solutions. However, the company's strong brand reputation and customer loyalty mitigate this threat.

Bargaining Power Of Customers

The bargaining power of customers is low due to the company's strong market position and the lack of significant buyer concentration in the healthcare IT market.

Bargaining Power Of Suppliers

The bargaining power of suppliers is medium due to the presence of several large suppliers of healthcare IT solutions. However, the company's strong relationships with suppliers and its ability to negotiate favorable terms mitigate this threat.

Threat Of New Entrants

The threat of new entrants is low due to the high barriers to entry in the healthcare IT market, including the need for significant capital investment and regulatory compliance.

Intensity Of Rivalry

The intensity of rivalry is high due to the presence of several established players in the healthcare IT market, leading to intense competition for market share.

9. SWOT Analysis

Strength

Weaknesses

Opportunities

Threats

10. Capital Structure

10.a. Balance Sheet

10.b. Weighted Average Cost of capital

Value
Debt Weight 53.46%
Debt Cost 4.92%
Equity Weight 46.54%
Equity Cost 8.90%
WACC 6.77%
Leverage 114.87%

11. Quality Control: CompuGroup Medical SE & Co. KGaA passed 4 out of 9 key points

12.a Historical Valuation

12.b Price/Earnings Ratio

12.c Margin Valuation

12.d Peers Valuation

Peers Group Analysis

Stock-Card
Nexus

A-Score: 5.6/10

Value: 2.0

Growth: 7.2

Quality: 7.9

Yield: 0.0

Momentum: 9.0

Volatility: 7.7

1-Year Total Return ->

View Full Report
Stock-Card
CompuGroup Medical

A-Score: 4.7/10

Value: 4.6

Growth: 4.2

Quality: 4.1

Yield: 0.6

Momentum: 9.5

Volatility: 5.0

1-Year Total Return ->

View Full Report
Stock-Card
Equasens

A-Score: 4.2/10

Value: 4.6

Growth: 4.9

Quality: 7.2

Yield: 4.4

Momentum: 1.0

Volatility: 3.0

1-Year Total Return ->

View Full Report
Stock-Card
Cegedim

A-Score: 4.0/10

Value: 10.0

Growth: 3.7

Quality: 2.3

Yield: 0.0

Momentum: 2.0

Volatility: 6.0

1-Year Total Return ->

View Full Report
Stock-Card
SOPHiA GENETICS

A-Score: 3.8/10

Value: 6.8

Growth: 4.6

Quality: 3.7

Yield: 0.0

Momentum: 8.0

Volatility: 0.0

1-Year Total Return ->

View Full Report
Stock-Card
Surgical Science Sweden

A-Score: 2.9/10

Value: 1.9

Growth: 7.7

Quality: 6.1

Yield: 0.0

Momentum: 0.5

Volatility: 1.0

1-Year Total Return ->

View Full Report

Peers Metrics

12.e Scoring Insights

12.f DCF BETA

Parameters

Short Term Growth

Short term Time

Long-Term Growth

WACC

Target Price

22.66$

Current Price

22.66$

Potential

-0.00%

Expected Cash-Flows